Performing injections with a bulking agent consisting of nonanimal stabilized hyaluronic acid and dextranomer is a well-tolerated and efficacious treatment for mild to moderate fecal incontinence. Here, we discuss a case of a patient with a history of a bulking procedure for fecal incontinence who presented to the obstetrics/gynecology clinic for evaluation of a new vaginal "cyst," which was excised. Histopathologic examination revealed migrated bulking agent within the excised specimen.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PGP.0000000000000800 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Study on Multifield Migration and Evolution Law of the Oxidation Heating Process of Coal Spontaneous Combustion in Dynamic Goaf.
ACS Omega
April 2023
College of Safety and Emergency Management Engineering, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China.
To study the dynamic evolution law of the oxidation heating process of coal spontaneous combustion in the goaf during the advancing process of the working face, a dynamic model of oxidation heating of coal spontaneous combustion in the goaf was established on the basis of deformed geometry. Through numerical simulation research, the evolution and migration laws of seepage field, oxygen concentration field, temperature field, and high-temperature area of coal spontaneous combustion in the goaf during the advancement of the working face was obtained. The results indicate that the distribution of the bulking coefficient, porosity, and permeability of the falling coal and rock mass in the goaf is nonuniform.
View Article and Find Full Text PDFUp-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures.
Medicina (Kaunas)
June 2022
Obstetrics and Gynecology Unit, IRCCS San Raffaele Hospital, Vita-Salute University, 20132 Milano, Italy.
To avoid complications related to mid-urethral slings (MUS), alternative procedures to treat stress urinary incontinence (SUI), such as urethral bulking agents (UBAs) have been adopted. The aim of this review is to narratively report the efficacy and safety of UBAs for SUI treatment. For this review, research from PubMed and EMBASE was performed to evaluate relevant studies that were undertaken from January 2012 to January 2022.
View Article and Find Full Text PDFAn evaluation of the long-term effectiveness of Gatekeeper™ intersphincteric implants for passive faecal incontinence.
Tech Coloproctol
July 2022
Department of Colorectal Surgery, Forth Valley Royal Hospital, Larbert, Stirlingshire, Scotland, UK.
Background: Implantation of Gatekeeper™ prostheses presents an option for the treatment of passive faecal incontinence (FI). Whilst preliminary results are encouraging, long-term data regarding its sustained benefit are limited. The aim of this study was to assess and evaluate the long-term clinical function and quality of life of patients with passive faecal incontinence who were treated with Gatekeeper™ prostheses.
View Article and Find Full Text PDFAssessing the impact of lime on chromium migration in soil caused by basic chromium sulfate in tannery.
Environ Technol
April 2023
College of Architecture and Environment, Sichuan University, Chengdu, People's Republic of China.
Chromium (Cr) pollution is the primary pollution problem of the soil in tannery. However, the effect of tanning chemicals on Cr migration in soil has not been clearly elucidated. Column leaching tests were designed in this study to reveal the transport and transformation of Cr from basic chromium sulfate (BCS) into soil and the effects of lime on Cr migration and transformation.
View Article and Find Full Text PDFMagnetic Agarose Microspheres/Hyaluronic Acid Hydrogel as a Trackable Bulking Agent for Vesicoureteral Reflux Treatment.
Front Bioeng Biotechnol
October 2021
State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, and Laboratory of Advanced Materials, Fudan University, Shanghai, China.
Vesicoureteral reflux (VUR) is one of the most common congenital anomalies in the kidney and the urinary tract. Endoscopic subureteral injection of a bulking agent has become popular in VUR treatment due to its high success rates, few complications, and a straightforward procedure. In this study, a novel magnetic bulking agent was prepared by embedding FeO magnetic nanoparticles in cross-linked agarose microspheres with diameters of 80-250 μm and dispersing the magnetic microspheres in a hyaluronic acid hydrogel.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!